Clinical Trials Directory

Trials / Completed

CompletedNCT01394289

Biological Standardization of Lolium Perenne Allergen Extract

Biological Standardization of Lolium Perenne Allergen Extract to Determine the Biological Activity in HEP Units

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Laboratorios Leti, S.L. · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to determine the biologic activity of a Lolium perenne allergen extract in histamine equivalent prick (HEP) units, in order to be used as in-house reference preparation (IHRP).

Detailed description

Four concentrations of Lolium perenne allergen extract, together with a positive and negative control, using 10 mg/ml histamine dihydrochloride solution and a glycerinated phenol saline solution, respectively, will be tested in every patient in duplicate on the volar surface of the forearm.

Conditions

Interventions

TypeNameDescription
BIOLOGICALLolium allergen extractThis is an open, unblinded and non randomized biological as proposed by the Nordic Guidelines. Four concentrations of Lolium perenne allergen extract, together with a positive and negative control, using 10 mg/ml histamine dihydrochloride solution and a glycerinated phenol saline solution, respectively, will be tested in every patient in duplicate on the volar surface of the forearm. This test will be referred to as the Titrated Skin Prick test.

Timeline

Start date
2011-09-01
Primary completion
2011-11-01
Completion
2011-11-01
First posted
2011-07-14
Last updated
2012-08-27

Locations

2 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT01394289. Inclusion in this directory is not an endorsement.